No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CRH240719P72500
- 0.81
- -0.37-31.36%
15min DelayClose Jun 28 16:00 ET
0.81High0.81Low
0.81Open1.18Pre Close1 Volume84 Open Interest72.50Strike Price81.00Turnover35.07%IV4.39%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier19DDays to Expiry0.81Extrinsic Value100Contract SizeAmericanOptions Type-0.3144Delta0.0581Gamma57.68Leverage Ratio-0.0522Theta-0.0120Rho-18.13Eff Leverage0.0620Vega
Intraday
- 5D
- Daily
News
Daily short sale tracking: Nu Holdings's short volume increased by 23 million, with a short sale ratio of 25%
Nu Holdings(NU.US) ranked top of the list had the largest change in short volume (23.22 million shares), and the short volume ratio of Viking Holdings(VIK.US) reached 71.96%. See more about the top 10 list of short selling volume changes in the latest trading day of the US stock market.
CRH Plc's (NYSE:CRH) Intrinsic Value Is Potentially 61% Above Its Share Price
Key Insights The projected fair value for CRH is US$120 based on 2 Stage Free Cash Flow to Equity Current share price of US$74.50 suggests CRH is potentially 38% undervalued Our fair value estimat
CRH Plc UK Regulatory Announcement: Total Voting Rights
DUBLIN--(BUSINESS WIRE)-- CRH plc ("the Company") Voting Rights and Capital-----------------------In accordance with DTR 5.6.1 of the UK's Financial Conduct Authority's Disclosure Guidance and Transpa
J.P. Morgan Maintains CRH PLC(CRH.US) With Buy Rating, Maintains Target Price $96
J.P. Morgan analyst Elodie Rall maintains $CRH PLC(CRH.US)$ with a buy rating, and maintains the target price at $96.According to TipRanks data, the analyst has a success rate of 63.4% and a total ave
Express News | CRH PLC - Report on Payments to Govts
European Equities Traded in the US as American Depositary Receipts Move Higher in Thursday Trading
European equities traded in the US as American depositary receipts were trending moderately higher late Thursday morning, rising 0.62% to 1,426.64 on the S&P Europe Select ADR Index. From continental
Comments
G'day, mooers! Check out the latest news on today's stock market!
• US major indexs fell
• ASX 200 rises by broad buying; ANZ sells stake in Malaysian bank
• Stocks to watch: Telix Pharmaceuticals, Adbri, Pro Medicus
Wall Street Summary
Indexs fell Thursday after harsh earnings reactions. Overall, there was more green than red out there, but by the numbers after the close, the $S&P 500 Index(.SPX.US$ traded -0.60%,...
• US major indexs fell
• ASX 200 rises by broad buying; ANZ sells stake in Malaysian bank
• Stocks to watch: Telix Pharmaceuticals, Adbri, Pro Medicus
Wall Street Summary
Indexs fell Thursday after harsh earnings reactions. Overall, there was more green than red out there, but by the numbers after the close, the $S&P 500 Index(.SPX.US$ traded -0.60%,...
2
CRH's dividend is seen as sustainable, backed by profit and cash flow. Its growing earnings and low payout ratios hint at a promising long-term dividend stock. The firm's consistent dividend and earnings growth show a commitment to rewarding shareholders.
1
Despite lower than expected Q4 numbers, investors are not worried due to the company's positive outlook for 2024, driven by significant infrastructure investment and re-industrialization activity across key markets in North America and Europe.
The strong EPS growth and insider buying at CRH indicate a positive outlook for the company. The growth rate and insider activity suggest that the company could be a good investment opportunity.
1
The market's view of CRH has improved over the last five years, likely due to consistent earnings growth. Recent insider buying and strong share price momentum suggest potential investment opportunities.
Read more